ArticleLow-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study
References (40)
- et al.
Naltrexone in autistic children: behavioral symptoms and attentional learning
J Am Acad Child Adolesc Psychiatry
(1993) - et al.
CSF beta-endorphins in childhood neuropsychiatric disorders
Brain Dev
(1990) - et al.
β-Endorphin concentrations in serum, hypothalamus and central gray of hypophysectomized and mediobasal hypothalamus lesioned rats
Brain Res
(1982) - et al.
Effects of naltrexone on infantile autism
Lancet
(1988) A neurochemical theory of autism
Trends Neurosci
(1979)- et al.
Reduction of elevated CSF beta-endorphin by fenfluramine in infantile autism
Pediatr Neurol
(1987) - et al.
A modified enzymatic-isotopic microassay for serotonin (5-HT) using 5-HT-acetyltransferase partially purified from Drosophila
Life Sci
(1983) - et al.
Low plasma immunoreaction β-endorphin levels in autistics
J Am Acad Child Adolesc Psychiatry
(1988) - et al.
Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis
Am J Ment Retard
(1989)
The Behavioral Summarized Evaluation: validity and reliability of a scale for the assessment of autistic behaviors
J Autism Dev Disord
Naltrexone in autistic children: a double-blind and placebo-controlled study
Psychopharmacol Bull
Naltrexone in infantile autism
Psychopharmacol Bull
Radioenzymatic assay of plasma and urinary catecholamines in man and various animal species: physiological and pharmacological applications
Rationale for the administration of opiate antagonists in treating infantile autism
Am J Ment Defic
Children's Psychiatric Rating Scale
Psychopharmacol Bull
Endorphin activity in childhood psychosis: spinal levels of 24 cases
Arch Gen Psychiatry
Normative data on revised Conners parent and teacher rating scales
J Abnorm Child Psychol
Radioimmunoassays for alpha-endorphin and beta-endorpnin
Biochem Biophys Commun
Effects of opioid receptor antagonists in the treatment of autism and self-injurious behavior
Cited by (105)
The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present
2021, Progress in Neuro-Psychopharmacology and Biological PsychiatryThe aetiology of social deficits within mental health disorders: The role of the immune system and endogenous opioids
2020, Brain, Behavior, and Immunity - HealthCitation Excerpt :They noted that the “behavioural change was also accompanied by an increase of T-helper-inducers and decrease in T-cytotoxic-suppressor, resulting in a normalization of the CD4/CD8 ratio” (p. 351). Other research looking at the effect of Naltrexone on ASD also shows some improvement (Bouvard et al., 1995; Campbell et al., 1993; Kolmen et al., 1995), especially with self-injurious behaviour (Eichaar et al., 2006; Sandman and Kemp, 2011) but only in a subgroup of those with ASD (Roy et al., 2015). Given the MOR-Balance model of ASD proposed by Pellissier et al. (2018), this subgroup may be the one with excessive MOR activity, compared to others with ASD who have insufficient MOR activity or some other biochemical cause of their symptoms.
Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy
2018, International ImmunopharmacologyReconciling cognitive and affective neuroscience perspectives on the brain basis of emotional experience
2017, Neuroscience and Biobehavioral ReviewsCitation Excerpt :Aside from human self-reports already noted, which are generally consistent with the above thesis (Panksepp, 1985), another relevant approach would be to test novel psychiatric predictions. That has been achieved to a modest extent for childhood autism (Bouvard et al., 1995) and robustly in the treatment of depression (for reviews, see Panksepp, 2015a; Panksepp et al., 2014). #2.
The Neurobiology of Social Affiliation and Pair Bonding
2017, Hormones, Brain and Behavior: Third Edition